Browsing by Author Pérez Galán, Patricia
Showing results 1 to 15 of 15
| Issue Date | Title | Author(s) |
|---|---|---|
| 19-Jan-2022 | Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis | Corbera Bellalta, Marc; Alba Rovira, Roser; Muralidharan, Sujatha; Espígol Frigolé, Georgina; Ríos Garcés, Roberto; Marco Hernández, Javier; Denuc Isern, Amanda; Kamberovic, Farah; Pérez Galán, Patricia; Joseph, Alexandra; Andrea, Annalisa d'; Bondensgaard, Kent; Cid, María C. |
| 19-Dec-2015 | CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia | Montraveta, Arnau; Lee-Vergés, Eriong; Roldán, Jocabed; Jiménez, Laura; Cabezas, Sandra; Clot, Guillem; Pinyol, Magda; Xargay i Torrent, Sílvia; Rosich, Laia; Arimany Nardi, Cristina; Aymerich Gregorio, Marta; Villamor i Casas, Neus; López Guillermo, Armando; Pérez Galán, Patricia; Roué, Gaël; Pastor Anglada, Marçal; Campo Güerri, Elias; López-Guerra, Mónica; Colomer Pujol, Dolors |
| 15-Mar-2022 | Contribution of hypoxia inducible factor, HIF1α, to vascular inflammation and remodeling in giant cell arteritis (GCA). Effects of GM-CSF receptor blockade on HIF1α stabilization | Alba Rovira, Roser |
| 11-Jul-2019 | Daratumumab displays in vitro and in vivo anti-tumor activity in models of B cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens | Vidal Crespo, Anna; Matas Céspedes, Alba; Rodríguez, Vanina; Rossi, Cédric; Valero, Juan G.; Serrat, Neus; Sanjuan Pla, Alejandra; Menéndez Buján, Pablo; Roué, Gaël; López Guillermo, Armando; Giné Soca, Eva; Campo Güerri, Elias; Colomer Pujol, Dolors; Bezombes, Christine; Lammerts van Bueren, J.; Chiu, Christopher; Doshi, Parul; Pérez Galán, Patricia |
| 6-Dec-2018 | Development of a novel anti-CD19 chimeric antigen receptor: A paradigm for an affordable CAR T cell production at academic institutions | Castella, Maria; Boronat, Anna; Martín Ibáñez, Raquel; Rodríguez, Vanina; Suñé, Guillermo; Caballero, Miguel; Marzal, Berta; Pérez-Amill, Lorena; Martín-Antonio, Beatriz; Castaño, Julio; Bueno, Clara; Balagué, Olga; González-Navarro, Europa Azucena; Serra Pagès, Carles; Engel Rocamora, Pablo; Vilella, Ramon; Benítez-Ribas, Daniel; Ortiz-Maldonado Gibson, Valentín; Cid Vidal, Joan; Tabera, Jaime; Canals i Coll, Josep M.; Lozano, Miquel; Baumann, Tycho; Vilarrodona, Anna; Trias, Esteve; Campo Güerri, Elias; Menéndez Buján, Pablo; Urbano Ispizua, Álvaro; Yagüe, Jordi; Pérez Galán, Patricia; Rives, Susana; Delgado, Julio (Delgado González); Juan, Manel |
| Feb-2019 | Differential expression of long non-coding RNAs are related to proliferation and histological diversity in follicular lymphomas | Roisman, Alejandro; Castellano, Giancarlo; Navarro, Alba; González Farré, Blanca; Pérez Galán, Patricia; Esteve Codina, Anna; Dabad, Marc; Heath, Simon C.; Gut, Marta; Bosio, Mattia; Bellot, Pau; Salembier, Philippe; Oliveras, Alberto; Slavutsky, Irma; Magnano, Laura; Horn, Heike; Rosenwald, Andreas; Ott, German; Aymerich Gregorio, Marta; López Guillermo, Armando; Jares Gerboles, Pedro; Martín-Subero, José Ignacio; Campo Güerri, Elias; Hernández, Luis |
| 25-Jul-2014 | Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma | Rosich, Laia; Montraveta, Arnau; Xargay i Torrent, Sílvia; López-Guerra, Mónica; Roldán, Jocabed; Aymerich Gregorio, Marta; Salaverria Frigola, Itziar; Beà Bobet, Sílvia M.; Campo Güerri, Elias; Pérez Galán, Patricia; Roué, Gaël; Colomer Pujol, Dolors |
| 1-Jan-2019 | High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation | Carreras, Joaquim; López Guillermo, Armando; Kikuti, Yara Yukie; Itoh, Johbu; Masashi, Miyaoka; Ikoma, Haruka; Tomita, Sakura; Hiraiwa, Shinichiro; Hamoudi, Rifat; Rosenwald, Andreas; Leich, Ellen; Martínez, Antonio; Roncador, Giovanna; Villamor i Casas, Neus; Colomo Saperas, Lluís; Pérez Galán, Patricia; Tsuji, Noriko M.; Campo Güerri, Elias; Nakamura, Naoya |
| 28-Nov-2016 | Innovative therapies targeting tumor-microenvironment crosstalk in indolent B-cell non-Hodgkin lymphomas | Matas Céspedes, Alba |
| 1-Apr-2019 | Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma | Recasens Zorzo, Clara; Cardesa Salzmann, Teresa; Petazzi, Paolo; Ros Blanco, Laia; Esteve Arenys, Anna; Clot, Guillem; Guerrero Hernández, Martina; Rodríguez, Vanina; Soldini, Davide; Valera Barros, Alexandra; Moros Sanz, Alexandra; Climent, Fina; González Barca, Eva; Mercadal, Santiago; Arenillas Rocha, Leonor; Calvo, Xavier; Mate, José L.; Gutiérrez García, Gonzalo; Casanova Rigat, Isolda; Mangues Bafalluy, Ramon; Sanjuan Pla, Alejandra; Bueno, Clara; Menéndez Buján, Pablo; Martínez, Antonio; Colomer Pujol, Dolors; Estrada Tejedor, Roger; Teixidó, Jordi; Campo Güerri, Elias; López Guillermo, Armando; Borrell, José Ignacio; Colomo Saperas, Lluís; Pérez Galán, Patricia; Roué, Gaël |
| 19-Jun-2018 | Preclinical evaluation of the antitumor activity of a new CXCR4 inhibitor: a novel therapeutic approach in diffuse large B-cell lymphoma | Recasens Zorzo, Clara |
| 15-Feb-2014 | Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma | Montraveta, Arnau; Xargay i Torrent, Sílvia; López-Guerra, Mónica; Rosich, Laia; Pérez Galán, Patricia; Salaverria Frigola, Itziar; Beà Bobet, Sílvia M.; Kalko, Susana; Frías Sanchez, Mercè de; Campàs Moya, Clara; Roué, Gaël; Colomer Pujol, Dolors |
| 28-Apr-2017 | Targeting the crosstalk between tumor cells and microenvironment: a new therapeutic approach for the treatment of lymphoid neoplasms | Vidal Crespo, Anna |
| 19-Feb-2019 | Targeting tumor microenvironment crosstalk through GPCR receptors and PI3K pathway | Guerrero Hernández, Martina |
| Oct-2017 | The BET bromodomain inhibitor CPI203 improves lenalidomide activity in in vitro and in vivo models of multiple myeloma by synergistic blockade of Ikaros and Myc signaling. | Díaz Sánchez, Tania; Rodríguez, Vanina; Lozano Garcia, Ester; Mena Jaramillo, Mari Pau; Calderón, Marcos; Rosiñol Dachs, Laura; Martínez, Antonio; Tovar, Natalia; Pérez Galán, Patricia; Bladé, J. (Joan); Roué, Gaël; Fernández de Larrea Rodríguez, Carlos José |